Tier 2 — strong

Combination of simvastatin with berberine improves the lipid-lowering efficacy

Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD
Metabolism: clinical and experimental 2008 57(8):1029-1037

Bibliography

PubMed
PMID 18640378
DOI
10.1016/j.metabol.2008.01.037
Funding
Funding was not established from the accessible source; this is not a declaration of no funding.
Competing interests
A complete competing-interest declaration was not available in the accessible source; no absence of conflicts is inferred.

Study snapshot

DesignHuman intervention with separate preclinical experiments
ModelHuman participants; see population
Sample63 hypercholesterolemic patients; separate rat/cell experiments
InterventionBerberine, simvastatin or their combination
DurationHuman duration not specified in indexed abstract
EndpointsTotal and LDL cholesterol; Triglycerides and apolipoproteins; Metabolic and vascular biomarkers

What the study showed, in plain terms

The combination lowered lipids more than either monotherapy in a small clinical comparison, with separate receptor-mechanism experiments.

Key findings

  • Combination-arm LDL cholesterol fell by about 31.8% from baseline.
  • The clinical comparison did not measure cardiovascular event prevention.

What this study can and cannot tell us

Combination effects cannot be attributed to berberine alone; this is not a general endorsement of unsupervised statin co-use.

Source detail: indexed abstract and bibliographic record; unavailable methods or disclosures are identified rather than assumed.

Related papers in the corpus

Tier 2
Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials
Zhao JV et al. · JACC. Asia · 2026
Tier 2
Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial
Zhao JV et al. · Nutrients · 2021
Tier 2
Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial
León-Martínez JM et al. · Journal of medicinal food · 2021
Tier 2
Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study
Spigoni V et al. · International journal of molecular sciences · 2017
Tier 2
[Therapeutic Effects of Berberine Capsule on Patients with Mild Hyperlipidemia]
Wang L et al. · Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine · 2016

Citation network

Articles citing this research paper

1 article

Biohack Blueprint analyses that reference this study in their evidence base.

Editorial review

Reviewed by the Biohack Blueprint research team

Last verified

Dr. Khaled Mahmoud, MBBChCritical Care Medicine, Longevity Science & Editorial Direction Dr. Amr Yasser, PhDCardiometabolic, Musculoskeletal, Gut & Bioavailability Dr. Abdulla Mostafa, PhDCellular Senescence, Neurological, Mitochondrial & Brain-Ageing Biology